{"id":819266,"date":"2026-07-21T15:00:35","date_gmt":"2026-07-21T13:00:35","guid":{"rendered":"https:\/\/podcast.rs\/ozempic-wegovy-i-drugi-medikamenti-za-mrsavljenje\/"},"modified":"2026-08-11T03:23:48","modified_gmt":"2026-08-11T01:23:48","slug":"ozempic-wegovy-i-drugi-medikamenti-za-mrsavljenje","status":"publish","type":"post","link":"https:\/\/podcast.rs\/en\/ozempic-wegovy-i-drugi-medikamenti-za-mrsavljenje\/","title":{"rendered":"Ozempic, Wegovy i drugi medikamenti za mr\u0161avljenje"},"content":{"rendered":"<p>Tr\u017ei\u0161te lijekova koji su prvobitno bili namijenjeni lije\u010denju dijabetesa 2, ali su u me\u0111uvremenu izazvali revoluciju u sektoru preparata za mr\u0161avljenje, se i dalje \u0161iri. Nakon nekoliko ve\u0107 poznatih medikamenata u obliku injekcija, od kojih je najpoznatiji Ozempic, sada na tr\u017ei\u0161te dolaze i lijekovi koji se uzimaju oralnim putem. Nenad Kreizer i Filip Slavkovi\u0107 predstavljaju novosti na polju medikamenata za mr\u0161avljenje, a dijabetologinja Zelija Velija-A\u0161imi upozorava na rizike.<\/p>","protected":false},"excerpt":{"rendered":"<p>Tr\u017ei\u0161te lijekova koji su prvobitno bili namijenjeni lije\u010denju dijabetesa 2, ali su u me\u0111uvremenu izazvali revoluciju u sektoru preparata za mr\u0161avljenje, se i dalje \u0161iri. Nakon nekoliko ve\u0107 poznatih medikamenata u obliku injekcija, od kojih je najpoznatiji Ozempic, sada na tr\u017ei\u0161te dolaze i lijekovi koji se uzimaju oralnim putem. Nenad Kreizer i Filip Slavkovi\u0107 predstavljaju&#8230;<\/p>","protected":false},"author":3,"featured_media":659662,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[183],"tags":[],"class_list":["post-819266","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cosmo"],"_links":{"self":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts\/819266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/comments?post=819266"}],"version-history":[{"count":1,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts\/819266\/revisions"}],"predecessor-version":[{"id":819440,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts\/819266\/revisions\/819440"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/media\/659662"}],"wp:attachment":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/media?parent=819266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/categories?post=819266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/tags?post=819266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}